| mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
| mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.003 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.006 |
| mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.006 |
| mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.007 |
| mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
| mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |